Get the Stockscreener App
0.5982
0.00%
+0.00
Bionexus Gene Lab Corp Stock (BGLC) Forecast
The Bionexus Gene Lab Corp (BGLC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.9976, representing a +233.93% increase from the current price of $0.5982. The highest analyst price target is $3.4924, and the lowest is $0.5028.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BGLC Price Target
Average 2.10
(+251.05% Upside)
Is Bionexus Gene Lab Corp (BGLC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.15 | Neutral |
| STOCH(9,6) | 27.72 | Neutral |
| STOCHRSI(14) | 30.29 | Neutral |
| MACD(12,26) | -0.0207 | Buy |
| ADX(14) | 45.31 | Buy |
| William %R | -88.31 | Buy |
| CCI(14) | -57.12 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6022
Sell
|
0.6056
Sell
|
| MA20 |
0.6242
Sell
|
0.6205
Sell
|
| MA50 |
0.678
Sell
|
0.6368
Sell
|
| MA100 |
0.564
Buy
|
0.00
Buy
|
| MA200 |
0.282
Buy
|
0.00
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BGLC could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BGLC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 45.15 indicates that BGLC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 27.72 indicates that BGLC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.29 indicates that BGLC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.31 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.12 indicates that BGLC is still oversold but not to an extreme extent.
Long-term BGLC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bionexus Gene Lab Corp financial reports and earnings history, Bionexus Gene Lab Corp (BGLC) stock could reach $2.0843 by 2030, $5.0559 by 2040 and $8.0991 by 2050. See the projected annual prices until 2050 of the Bionexus Gene Lab Corp stock below:
- Bionexus Gene Lab Corp (BGLC) is expected to reach an average price of $3.6317 in 2035, with a high prediction of $4.0565 and a low estimate of $3.4332. This indicates an $507.11% rise from the last recorded price of $0.5982.
- Bionexus Gene Lab Corp (BGLC) stock is projected to chart a bullish course in 2040, with an average price target of $4.3602, representing an $628.88% surge from its current level. The forecast ranges from a conservative $4.356 to a sky-high $5.0559.
- Our analysts predict Bionexus Gene Lab Corp (BGLC) to jump 931.77% by 2045, soaring from $5.7242 to an average price of $6.172, potentially reaching $8.7138. While $5.7242 is the low estimate, the potential upside is significant.
- Bionexus Gene Lab Corp (BGLC) stock is expected to climb by 2050, reaching an average of $7.8283, a $1,209% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.0991 and $7.6644, respectively, highlighting the market's uncertainty.
Bionexus Gene Lab Corp Stock (BGLC) Year by Year Forecast
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2024
Our forecast for BGLC stock price in 2024 now indicates an average price target of $1.9976 with a high forecast of $3.5948 and a low forecast of $0.4004. The average prediction reflects an increase of +233.93% from the last recorded price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.1324 | $0.5028 | $3.4924 | +89.30% |
| July, 2024 | $0.8222 | $0.6542 | $1.3058 | +37.44% |
| August, 2024 | $0.7731 | $0.6971 | $0.9375 | +29.23% |
| September, 2024 | $0.9009 | $0.6909 | $1.1109 | +50.61% |
| October, 2024 | $0.6689 | $0.6073 | $0.7978 | +11.82% |
| November, 2024 | $0.8866 | $0.6052 | $3.5948 | +48.21% |
| December, 2024 | $0.9288 | $0.7583 | $1.4116 | +55.27% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2025
Bionexus Gene Lab Corp Stock (BGLC) is expected to reach an average price of $2.2525 in 2025, with a high prediction of $3.7995 and a low estimate of $0.7054. This indicates an +276.54% rise from the last recorded price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.8216 | $0.8018 | $1.2218 | +37.35% |
| February, 2025 | $0.8072 | $0.7892 | $0.9026 | +34.94% |
| March, 2025 | $0.7688 | $0.7054 | $0.8968 | +28.51% |
| April, 2025 | $0.8814 | $0.7075 | $3.6971 | +47.34% |
| May, 2025 | $1.0475 | $0.9145 | $1.5174 | +75.11% |
| June, 2025 | $0.9326 | $0.9128 | $1.3328 | +55.90% |
| July, 2025 | $0.859 | $0.857 | $1.0143 | +43.60% |
| August, 2025 | $0.8427 | $0.8035 | $0.9958 | +40.87% |
| September, 2025 | $0.9855 | $0.8099 | $3.7995 | +64.74% |
| October, 2025 | $1.1394 | $1.0195 | $1.6232 | +90.48% |
| November, 2025 | $1.0406 | $1.0237 | $1.4437 | +73.96% |
| December, 2025 | $1.0005 | $0.9016 | $1.0945 | +67.26% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2026
The predicted value for Bionexus Gene Lab Corp (BGLC) in 2026 is set at an average of $2.5095. Estimates vary from a peak of $4.1067 to a trough of $0.9123, indicating an +319.51% surge from the present price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9332 | $0.9187 | $1.0947 | +56.01% |
| February, 2026 | $1.2397 | $0.9123 | $3.9019 | +107.24% |
| March, 2026 | $1.2478 | $1.1918 | $1.729 | +108.59% |
| April, 2026 | $1.1831 | $1.134 | $1.5546 | +97.77% |
| May, 2026 | $1.0987 | $0.9998 | $1.1974 | +83.66% |
| June, 2026 | $1.0348 | $1.0203 | $1.1937 | +72.98% |
| July, 2026 | $1.4068 | $1.0147 | $4.0043 | +135.17% |
| August, 2026 | $1.2973 | $1.2432 | $1.475 | +116.86% |
| September, 2026 | $1.4555 | $1.2455 | $1.6655 | +143.32% |
| October, 2026 | $1.2227 | $1.0979 | $1.2926 | +104.40% |
| November, 2026 | $1.7467 | $1.1171 | $4.1067 | +191.99% |
| December, 2026 | $1.4621 | $1.2787 | $1.9406 | +144.41% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bionexus Gene Lab Corp (BGLC) is $2.7537, with a high forecast of $4.3114 and a low forecast of $1.196. This indicates an +360.33% increase from the last price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4335 | $1.3524 | $1.5825 | +139.63% |
| February, 2027 | $1.5665 | $1.3565 | $1.7765 | +161.86% |
| March, 2027 | $1.2678 | $1.196 | $1.3916 | +111.94% |
| April, 2027 | $1.506 | $1.2194 | $4.209 | +151.75% |
| May, 2027 | $1.5687 | $1.3828 | $2.0464 | +162.24% |
| June, 2027 | $1.4872 | $1.4616 | $1.8874 | +148.61% |
| July, 2027 | $1.3856 | $1.3676 | $1.5732 | +131.63% |
| August, 2027 | $1.3677 | $1.2941 | $1.4906 | +128.63% |
| September, 2027 | $1.5059 | $1.3218 | $4.3114 | +151.74% |
| October, 2027 | $1.6926 | $1.5442 | $2.1522 | +182.94% |
| November, 2027 | $1.5981 | $1.5708 | $1.9983 | +167.15% |
| December, 2027 | $1.4425 | $1.4405 | $1.685 | +141.15% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2028
In 2028, Bionexus Gene Lab Corp (BGLC) is projected to reach an average price of $3.0054, with a high projection of $4.6186 and a low estimate of $1.3922. This indicates an +402.40% rise from the last price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.4467 | $1.3922 | $1.5895 | +141.84% |
| February, 2028 | $1.61 | $1.4242 | $4.4138 | +169.14% |
| March, 2028 | $1.7896 | $1.6491 | $2.258 | +199.16% |
| April, 2028 | $1.7113 | $1.68 | $2.1092 | +186.07% |
| May, 2028 | $1.5892 | $1.4903 | $1.7703 | +165.66% |
| June, 2028 | $1.5424 | $1.5274 | $1.6885 | +157.84% |
| July, 2028 | $1.8694 | $1.5266 | $4.5162 | +212.50% |
| August, 2028 | $1.8434 | $1.7893 | $2.3638 | +208.15% |
| September, 2028 | $1.8588 | $1.8002 | $2.2202 | +210.74% |
| October, 2028 | $1.6873 | $1.5884 | $1.8783 | +182.06% |
| November, 2028 | $2.2586 | $1.6281 | $4.6186 | +277.56% |
| December, 2028 | $2.0416 | $1.7992 | $2.4696 | +241.28% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2029
The 2029 price forecast for Bionexus Gene Lab Corp Stock (BGLC) is $3.2549 on average, with a high prediction of $4.8233 and a low estimate of $1.6865. This represents an +444.12% increase from the previous price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.9838 | $1.8985 | $2.1201 | +231.63% |
| February, 2029 | $2.1211 | $1.9111 | $2.3311 | +254.58% |
| March, 2029 | $1.8165 | $1.6865 | $1.8864 | +203.66% |
| April, 2029 | $2.3609 | $1.7287 | $4.7209 | +294.67% |
| May, 2029 | $2.102 | $1.9033 | $2.5754 | +251.38% |
| June, 2029 | $2.0939 | $2.0077 | $2.2276 | +250.03% |
| July, 2029 | $2.232 | $2.022 | $2.442 | +273.12% |
| August, 2029 | $1.8667 | $1.7846 | $1.9854 | +212.06% |
| September, 2029 | $2.1254 | $1.8294 | $4.8233 | +255.30% |
| October, 2029 | $2.2301 | $2.0073 | $2.6812 | +272.80% |
| November, 2029 | $2.1527 | $2.1169 | $2.5529 | +259.87% |
| December, 2029 | $1.964 | $1.946 | $2.2439 | +228.32% |
Bionexus Gene Lab Corp Stock (BGLC) Price Forecast for 2030
Bionexus Gene Lab Corp Stock (BGLC) is expected to reach an average price of $3.5066 in 2030, with a high forecast of $5.1305 and a low forecast of $1.8827. This signifies an +486.19% surge from the last price of $0.5982.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.9501 | $1.8827 | $2.0843 | +225.99% |
| February, 2030 | $2.1304 | $1.934 | $4.9257 | +256.14% |
| March, 2030 | $2.3376 | $2.1738 | $2.787 | +290.77% |
| April, 2030 | $2.2636 | $2.2261 | $2.6638 | +278.41% |
| May, 2030 | $2.0261 | $2.0241 | $2.3557 | +238.69% |
| June, 2030 | $2.0507 | $1.9808 | $2.1833 | +242.82% |
| July, 2030 | $2.3941 | $2.0355 | $5.0281 | +300.22% |
| August, 2030 | $2.4398 | $2.3728 | $2.8928 | +307.85% |
| September, 2030 | $2.3819 | $2.3353 | $2.7748 | +298.18% |
| October, 2030 | $2.1778 | $2.0789 | $2.4461 | +264.07% |
| November, 2030 | $2.1515 | $2.1314 | $2.2823 | +259.67% |
| December, 2030 | $2.499 | $2.1409 | $5.1305 | +317.76% |
2.56%
2.73%
Cap:
|
Volume (24h):